Group 2 (50–94% tumour necrosis)
| Age (years) | Sex | Maximum tumour size (mm) | pTNM stage | Fuhrman nuclear grade | Tumour subtype | Follow up (months) |
|---|---|---|---|---|---|---|
| DOOC, died of other causes; LTFU, lost to follow up; NED, no evidence of disease; PO, postoperatively. | ||||||
| 79 | M | 140 | 2 | 2 | Clear cell | NED (12) |
| 32 | M | 82 | 2 | 1 | Clear cell | NED (50) |
| 77 | F | 100 | 3b | 3 | Clear cell | Died PO |
| 41 | F | 28 | 1 | 2 | Clear cell | NED (65) |
| 65 | M | 160 | 3 | 2 | Clear cell | DOOC (11) |
| 68 | M | NR | Unknown | 3 | Clear cell | LTFU |
| 56 | F | 70 | 1 | 2 | Clear cell | NED (70) |
| 78 | M | 270 | 3 | 3 | Clear cell | Recurrence (50) |
| 72 | M | 95 | 3b | 3 | Clear cell | Died (22) |
| 67 | M | 120 | 2 | 2 | Papillary | NED (106) |